Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9), 1399-1405
- https://doi.org/10.1016/0277-5379(87)90126-x
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation studyEuropean Journal of Cancer and Clinical Oncology, 1987
- Phase I clinical trial and pharmacokinetics of carboplatin (nsc 241240) by single monthly 30-minute infusionCancer, 1986
- Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancerCancer Treatment Reviews, 1985
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- Carboplatin: the clinical spectrum to dateCancer Treatment Reviews, 1985
- Results of NCI-sponsored phase I trials with carboplatinCancer Treatment Reviews, 1985
- Cis-diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary reportCancer Treatment Reviews, 1985
- A Phase I trial of Cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-scheduleInvestigational New Drugs, 1984
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- Kinetics of cis‐dichlorodiammineplatinumClinical Pharmacology & Therapeutics, 1979